Brian Taylor Slingsby
Director, Mineralys Therapeutics, Inc.
Companies
- Mineralys Therapeutics, Inc.Board member Feb 9, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mineralys Therapeutics, Inc. MLYS7,805,718 shares2$163.4M at $20.93Sep 22, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 22, 2026Sold 104,320 shares at $28.81 of Mineralys Therapeutics, Inc.2
- Feb 19, 2026Other 6,200 shares of Mineralys Therapeutics, Inc.3
- Feb 19, 2026Other 6,200 shares of Mineralys Therapeutics, Inc.3
- Feb 19, 2026Granted 6,200 shares of Mineralys Therapeutics, Inc.3
- Mar 13, 2025Bought 259,259 shares at $13.50 of Mineralys Therapeutics, Inc.4
- Jul 24, 2024Sold 550,000 shares at $13.05 of Mineralys Therapeutics, Inc.5
- Feb 14, 2023Bought 250,000 shares at $16.00 of Mineralys Therapeutics, Inc.6
- Feb 14, 2023Converted 4,314,093 shares of Mineralys Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 20, 2026
- 4SEC EDGARForm 4 filed Apr 25, 2025
- 5SEC EDGARForm 4 filed Jul 26, 2024
- 6SEC EDGARForm 4 filed Feb 16, 2023